AM Biotechnologies develops DNA based affinity agents called X-aptamers, using proprietary technologies, as replacements for antibodies.
X-aptamers are chemically synthesized; they are stable in ambient environments with very long shelf life; and are rapidly produced in large quantities with easy quality control. We solve the problems associated with antibodies while delivering the same functionality. X-aptamers can be substituted for antibodies in virtually any application. We can develop thioaptamer affinity agents for your targets using our bead-based development service.